Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort-Reference-Cited by-同舟云学术

Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort

Published:2017-01-30 Issue:3 Volume:6 Page:547-554
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Liu Xiaoran¹^ORCID,Li Huiping¹,Shao Bin¹,Wu Jianmin¹,Kong Weiyao¹,Song Guohong¹,Jiang Hanfang¹,Wang Jing¹,Wan Fengling¹

Affiliation:

1. Key laboratory of Carcinogenesis and Translational Research (Ministry of Education); Department of breast oncology; Peking University Cancer Hospital & Institute; Fucheng Road No.52 Haidian District Beijing 100142 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference34 articles.

1. Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer;Wong-Brown;Breast Cancer Res. Treat.,2015

2. Therapies for triple negative breast cancer;Andreopoulou;Expert Opin. Pharmacother.,2015

3. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin. Cancer Res.,2007

4. Targeted therapies in triple-negative breast cancer;Marme;Breast Care (Basel).,2015

5. Targeted therapies for triple-negative breast cancer: combating a stubborn disease;Kalimutho;Trends Pharmacol. Sci.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of RAB25 Cooperates with Oncogenes in the Transformation of Human Mammary Epithelial Cells (HMECs) to Give Rise to Claudin-Low Tumors;BioMed Research International;2024-05-20

2. Germline variants associated with breast cancer in Khakass women of North Asia;Molecular Biology Reports;2022-12-28

3. Germline Testing in a Cohort of Patients at High Risk of Hereditary Cancer Predisposition Syndromes: First Two-Year Results from South Italy;Genes;2022-07-21

4. Current situation of programmed cell death protein 1/programmed cell death ligand 1 inhibitors in advanced triple-negative breast cancer;Chinese Journal of Cancer Research;2022

5. Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China;Breast Cancer Research and Treatment;2021-09-01